COMPASS Pathways plc CMPS
Updated: 9 Aug 2026
No signal published yet
We already track COMPASS Pathways and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.
Email when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Temporary check — not Firelda's published signal.
General analysis — not personal advice.
Want to follow COMPASS Pathways plc? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow COMPASS Pathways free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Recent News
On August 5, 2026, COMPASS Pathways reported its second-quarter 2026 financial results, highlighting a cash position of $433.3 million. The company confirmed that its rolling New Drug Application submission to the FDA for COMP360 in treatment-resistant depression remains on track for completion in the fourth quarter of 2026.
What Firelda Watch includes for COMPASS Pathways plc
Add the company to your watchlist and get all of this automatically.
- Free: 3 companies on your watchlist
- Change history and monitoring for every company you follow
- Sunday weekly brief — a short weekly roundup
- Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
Want to follow COMPASS Pathways plc? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow COMPASS Pathways free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more